


SKF reported Q2 2026 adjusted operating margin of 13.9% (up from 13.3% YoY) while net sales were essentially flat at 23,195m SEK; net profit more than doubled to 1,329m SEK. Rightsizing delivered ~350m SEK in realized benefits (1,400m SEK run-rate savings), but working capital outflows and separation/tariff timing pressures weighed on near-term cash flow. Management expects organic sales to strengthen modestly in Q3, with Q3 currency headwind of ~100m SEK and full-year capex cut to ~4bn SEK (from 5bn), yet investors sold the stock down 3.27% to ~$254.7, reflecting a continued preference for revenue acceleration over margin gains.
The equity is still pricing SKF like a mid-cycle industrial, not a self-help story with a cleaner capital structure. That creates a near-term mismatch: margin gains from rightsizing are real, but multiple expansion likely stays capped until the market sees sustained organic growth, not just cost takeout. The more interesting second-order effect is that the auto separation should reduce conglomerate drag and make the remaining industrial franchise easier to underwrite on ROCE and cash conversion, which matters more than a single quarter’s revenue print.
On competitive dynamics, the humanoids move is less about immediate revenue and more about securing a seat in a future high-spec bearing ecosystem before design-ins harden. If SKF can lock in application-level relationships now, the beneficiary set expands beyond bearing peers to include robotics suppliers and high-precision component vendors; the losers are incumbents with slower product-development cycles and weaker China access. In the next 1-3 months, the real catalyst is whether Q3 organic growth inflects enough to prove the margin improvement is not purely defensive.
The contrarian risk is that investors are underestimating how much of this quarter’s improvement is already in the numbers and overestimating the humanoids optionality. If Europe remains soft and FX/tariff noise persists, the stock can retrace despite better profitability. Over 6-18 months, the thesis is only falsified if separation fails, ROCE stalls below the mid-teens, or organic growth stays stuck near flat; otherwise, the combination of cleaner reporting and cash generation supports a rerating.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
mildly negative
Sentiment Score
-0.10
Ticker Sentiment